{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:33:38Z","timestamp":1780756418662,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jns.2020.116990","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T21:39:40Z","timestamp":1592516380000},"page":"116990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Clinical characteristics and brain MRI findings in myeloproliferative neoplasms"],"prefix":"10.1016","volume":"416","author":[{"given":"Koichiro","family":"Nagai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shimoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koiti","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2020.116990_bb0005","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jns.2020.116990_bb0010","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","article-title":"Some speculations on myeloproliferative syndromes","volume":"6","author":"Dameshek","year":"1951","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jns.2020.116990_bb0015","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4161\/cc.6.5.3919","article-title":"Oncogenes in myeloproliferative disorders","volume":"6","author":"Tefferi","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jns.2020.116990_bb0020","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1182\/blood-2011-02-339002","article-title":"Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients","volume":"117","author":"Carobbio","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jns.2020.116990_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ajh.25303","article-title":"Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management","volume":"94","author":"Tefferi","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jns.2020.116990_bb0030","first-page":"493","article-title":"Cerebrovascular complications of thrombocytosis","volume":"113","author":"Bogousslavsky","year":"1983","journal-title":"Schweiz Med. Wochenschr."},{"key":"10.1016\/j.jns.2020.116990_bb0035","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0035-3787(04)71140-6","article-title":"Cerebral infarction of arterial origin and haematological causation: the Lausanne experience and a review of the literature","volume":"160","author":"Gonthier","year":"2004","journal-title":"Rev. Neurol. (Paris)"},{"issue":"52","key":"10.1016\/j.jns.2020.116990_bb0040","first-page":"1969","article-title":"Polycythaemia vera: Klinik und Verlauf bei 86 Patienten [Polycythemia vera: clinical aspects and course in 86 patients]","volume":"118","author":"Egli","year":"1988","journal-title":"Schweiz Med. Wochenschr."},{"key":"10.1016\/j.jns.2020.116990_bb0045","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/jth.12265","article-title":"Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guiled management","volume":"11","author":"Casini","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jns.2020.116990_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-016-0242-9","article-title":"Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasm (MPN): analysis from the German SAL-MPN-resistry","volume":"9","author":"Kaifie","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jns.2020.116990_bb0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/M17-0028","article-title":"Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms; a population-based cohort study","volume":"168","author":"Hultcrantz","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2020.116990_bb0060","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.2010.31.8436","article-title":"Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European Leukemia Net","volume":"29","author":"Barbui","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jns.2020.116990_bb0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000448597","article-title":"Clinical characteristics of cerebrovascular pathology with patients suffering from Ph-negative myeloproliferative disease","volume":"6","author":"Tanashyan","year":"2016","journal-title":"Cerebrovasc. Dis. Extra"},{"key":"10.1016\/j.jns.2020.116990_bb0070","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.12.012","article-title":"Ischemic stroke with essential thrombocythemia: a case series","volume":"24","author":"Kato","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2020.116990_bb0075","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jns.2013.10.016","article-title":"Stroke in essential thrombocythemia","volume":"336","author":"Posfai","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2020.116990_bb0080","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1468-1331.2010.03183.x","article-title":"Ischaemic stroke and essential thrombocythemia: a series of 14 cases","volume":"18","author":"Richard","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2020.116990_bb0085","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jns.2019.01.035","article-title":"Radiological features and outcome of essential thrombocythemia-related stroke","volume":"398","author":"Kim","year":"2019","journal-title":"J. Neurol. Sci."},{"issue":"9","key":"10.1016\/j.jns.2020.116990_bb0090","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.leukres.2007.12.019","article-title":"Fully automated and super-rapid system for the detection of JAK2V617F mutation","volume":"32","author":"Tanaka","year":"2008","journal-title":"Leuk. Res."},{"key":"10.1016\/j.jns.2020.116990_bb0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.leukres.2015.11.002","article-title":"Clinical features of Japanese polycythemia vera and essential thrombocythemia patients harboring CALR, JAK2V617F, JAK2Ex12del, and MPLW515L\/K mutations","volume":"40","author":"Okabe","year":"2016","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.jns.2020.116990_bb0100","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/STROKEAHA.118.024143","article-title":"Atrial fibrillation and brain magnetic resonance imaging abnormalities The ARIC Study","volume":"50","author":"Berman","year":"2019","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.jns.2020.116990_bb0105","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.STR.19.10.1285","article-title":"White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors","volume":"19","author":"Fazekas","year":"1988","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jns.2020.116990_bb0110","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3174\/ajnr.A4176","article-title":"Cerebral microbleeds: different prevalence, topography, and risk factors depending on dementia diagnosis - the Karolinska imaging dementia study","volume":"36","author":"Shams","year":"2015","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.jns.2020.116990_bb0115","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1182\/blood-2006-08-042515","article-title":"Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera","volume":"109","author":"Landolfi","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jns.2020.116990_bb0120","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2012-07-443770","article-title":"Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial","volume":"121","author":"Gisslinger","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jns.2020.116990_bb0125","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.STR.0000068408.82115.D2","article-title":"Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study","volume":"34","author":"Vermeer","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2020.116990_bb0130","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.2005.07.062","article-title":"Vascular and neoplastic risk in a large cohort of patients with polycythemia vera","volume":"23","author":"Marchioli","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jns.2020.116990_bb0135","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1038\/bcj.2015.94","article-title":"Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia","volume":"5","author":"Barbui","year":"2015","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.jns.2020.116990_bb0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clml.2018.08.020","article-title":"Influence of blood count, cardiovascular risks, inherited thrombophilia, and JAK2 V617F burden allele on type of thrombosis in patients with Philadelphia chromosome negative myeloproliferative neoplasms","volume":"19","author":"Horvat","year":"2019","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"5","key":"10.1016\/j.jns.2020.116990_bb0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1532\/IJH97.06009","article-title":"Clinical features of polycythemia vera and essential thrombocythemia in Japan: retrospective analysis of a nationwide survey by the japanese elderly leukemia and lymphoma study group","volume":"83","author":"Dan","year":"2006","journal-title":"Int. J. Hematol."},{"issue":"6","key":"10.1016\/j.jns.2020.116990_bb0150","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12185-018-2428-0","article-title":"Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan","volume":"107","author":"Kamiunten","year":"2018","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.jns.2020.116990_bb0155","first-page":"101","article-title":"Thrombotic and bleeding complications in classical myeloproliferative neoplasms","volume":"39","author":"McMahon","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"issue":"6","key":"10.1016\/j.jns.2020.116990_bb0160","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1055\/s-0039-1693477","article-title":"Pathogenesis and management of thrombotic disease in myeloproliferative neoplasms","volume":"45","author":"Arachchillage","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.jns.2020.116990_bb0165","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000083877","article-title":"Cerebral infarction associated with essential thrombocythemia: an autopsy case study","volume":"19","author":"Ogata","year":"2005","journal-title":"Cerebrovasc. Dis."},{"issue":"2","key":"10.1016\/j.jns.2020.116990_bb0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1468-1331.2006.01616.x","article-title":"Circulating microemboli in patients with myeloproliferative disorders","volume":"14","author":"Weber","year":"2007","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2020.116990_bb0175","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.12.030","article-title":"Recurrent stroke with rapid development of intracranial stenosis in polycythemia vera","volume":"25","author":"Crespo","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20303270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20303270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:52:00Z","timestamp":1758383520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20303270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":35,"alternative-id":["S0022510X20303270"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.116990","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and brain MRI findings in myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.116990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116990"}}